
Relugolix is an oral hormone therapy used to treat advanced prostate cancer by reducing testosterone production. Lowering testosterone can slow the growth of prostate cancer cells that depend on this hormone for survival and multiplication.
| Generic Name | Relugolix |
| Strength | 120 mg |
| Manufacturer | Zydus |
| Packing | 30 Tablets |
| Prescribed For | Advanced prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Relugolix blocks gonadotropin-releasing hormone receptors in the pituitary gland. This reduces the production of hormones that instruct the testicles to make testosterone. Lower testosterone levels can slow the growth of prostate cancer that depends on this hormone.